ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,021Medicare Part D Prescriptions Filled, Including Refills

Rank: 180 out of 3647

$729K Total Retail Price of All Prescriptions

Rank: 502 out of 3647

1,090 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
54% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 1,090 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

30% of this provider’s 1,090 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 14,831 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,541 1,166 1 1
HYDROCODONE-ACETAMINOPHEN 1,414 865 S3 2 12
OMEPRAZOLE 924 652 3 3
AMLODIPINE BESYLATE 783 647 4 2
LEVOTHYROXINE SODIUM 757 605 5 5
LISINOPRIL-HYDROCHLOROTHIAZIDE 635 516 6 36
METFORMIN HCL 632 488 7 6
LISINOPRIL 622 486 8 4
METOPROLOL TARTRATE 544 430 9 7
MELOXICAM 516 379 10 33
FUROSEMIDE 436 351 11 8
GABAPENTIN 389 263 12 17
ATENOLOL 316 301 13 10
CITALOPRAM HBR 316 209 13 25
PROAIR HFA 310 166 15 62
OXYCODONE HCL 272 61 S2 16 75
POTASSIUM CHLORIDE 250 179 17 24
OXYCODONE-ACETAMINOPHEN 248 110 S2 18 91
ALPRAZOLAM 246 142 19 31
LOSARTAN POTASSIUM 235 195 20 11
TEMAZEPAM 233 175 21 47
ALLOPURINOL 202 194 22 37
LOSARTAN-HYDROCHLOROTHIAZIDE 197 171 23 48
ZOLPIDEM TARTRATE 190 112 24 14
CARISOPRODOL 185 14 R 25 115
GLYBURIDE 176 125 R 26 54
GLIMEPIRIDE 173 150 27 45
WARFARIN SODIUM 173 167 27 15
CARVEDILOL 173 151 27 20
PRAVASTATIN SODIUM 170 129 30 16
DIGOXIN 170 140 30 51
NAPROXEN 166 82 32 70
METOPROLOL SUCCINATE 162 128 33 18
SERTRALINE HCL 162 110 33 27
GLIPIZIDE 156 121 35 41
HYDROCHLOROTHIAZIDE 145 90 36 9
LOVASTATIN 142 120 37 21
OXYBUTYNIN CHLORIDE 130 115 38 107
ALENDRONATE SODIUM 121 93 39 23
GEMFIBROZIL 115 94 40 82
TAMSULOSIN HCL 112 91 41 28
GLYBURIDE-METFORMIN HCL 112 98 R 41 94
AMOXICILLIN 105 59 43 133
TRAMADOL HCL 103 62 44 22
TRAZODONE HCL 94 42 45 64
CRESTOR 89 65 46 19
FINASTERIDE 89 88 46 66
ADVAIR DISKUS 88 41 48 52
DOXAZOSIN MESYLATE 82 73 49 57
SPIRONOLACTONE 79 69 50 77
CLONIDINE HCL 77 61 51 46
CIPROFLOXACIN HCL 74 54 52 53
LORAZEPAM 73 46 53 73
PAROXETINE HCL 73 52 53 60
DIOVAN 72 71 55 40
LANTUS 69 39 56 59
BACLOFEN 67 48 57 97
CYCLOBENZAPRINE HCL 66 17 R 58 98
DONEPEZIL HCL 66 61 58 30
ISOSORBIDE MONONITRATE ER 66 58 58 56
AMITRIPTYLINE HCL 65 24 R 61 105
PRIMIDONE 65 59 61 288
VENTOLIN HFA 63 16 63 88
SPIRIVA 62 41 64 93
RANITIDINE HCL 62 54 64 29
OXYCODONE HCL-ACETAMINOPHEN 61 17 S2 66 104
METHADONE HCL 61 0 S2 66 174
PLAVIX 60 46 68 39
FLUOXETINE HCL 60 26 68 68
SULFAMETHOXAZOLE-TRIMETHOPRIM 57 49 70 110
INSULIN SYRINGE 57 31 70 76
CLOPIDOGREL 56 37 72 26
VIAGRA 55 42 73 69
FLUTICASONE PROPIONATE 54 35 74 32
LORATADINE 54 30 74 109
TERAZOSIN HCL 54 54 74 103
TORSEMIDE 53 44 77 215
FENOFIBRATE 53 18 77 50
AZITHROMYCIN 52 37 79 34
PHENYTOIN SODIUM EXTENDED 50 27 80 199
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.